Breast Cancer Survivorship

Introduction.- PART 1: DISEASE RECURRENCE.- Predicting Risk of Disease Recurrence.- Detection of Recurrence: Clinical Follow-Up.- Detection of Recurrence: Imaging Strategies.- Follow Up of Patients with Germline Mutations in High Risk Predisposition Genes.- PART 2: INTERVENTIONS TO REDUCE RISK OF RECURRENCE.- Endocrine Therapy.- Systemic Therapies to Reduce the Risk of Recurrence in Early Breast Cancer: New Strategies.- Exercise in Breast Cancer Survivors.- Dietary Components and Breast Cancer Survivorship.- PART 3: SEQUELAE OF EARLY BREAST CANCER AND ITS TREATMENT.- Identifying and Managing the Consequences of Treatment for Early Breast Cancer.- Managing Loco-Regional Complications of Breast Cancer Treatment.- The Role of Surgery in Breast Cancer Survivors.- Management of Menopausal Symptoms in Breast Cancer Survivors.- Bone Health.- Fertility.- Cardiotoxicity in Breast Cancer Survivors.- Second Primary Neoplasms Following a Diagnosis of Breast Cancer. - The Effects of Breast Cancer Treatments on Cognition.- Psychological Issues in Breast Cancer Survivorship.- Fatigue in Breast Cancer Survivors.

Dr Ring is a consultant in medical oncology at the Royal Marsden Hospital. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at the Royal Marsden, St George's and Guy's Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research at the University of London. In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant in Medical Oncology at the Royal Marsden Hospital. He has a specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a study which will investigate the role of aspirin in the treatment of over 3000 women with early breast cancer. He is Chair of the Committee for Clinical Research at the Royal Marsden Hospital and Institute of Cancer Research. Dr Ring has published widely in peer-reviewed journals and in 2015 edited the textbook "Problem-solving in older cancer patients."





He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology. 



Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden and Kingston Hospitals. Appointed to The Royal Marsden Consultant body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research at the University of London. 

Dr Parton is Lead Cancer Clinician in The